Tina Thethi, MD
Enriched profileAssociate Investigator, AdventHealth Translational Research Institute; Endocrinologist, AdventHealth Diabetes Institute · AdventHealth Research Institute
Tina Thethi is Associate Investigator, AdventHealth Translational Research Institute; Endocrinologist, AdventHealth Diabetes Institute at AdventHealth Research Institute. OpenAlex indexes 66 publications with 1,575 citations (h-index 17); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.
Data verified 11 Oct 2026
Overview
Updated 16 Oct 2026
Tina Thethi, M.D., is Associate Investigator, AdventHealth Translational Research Institute at AdventHealth Research Institute (Orlando, FL). The public record shows 66 publications with 1,575 citations (h-index 17), centered on Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Treatment and Management, Diabetes Management and Research. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 10 companies.
- Top research focus: Diabetes, Cardiovascular Risks, and Lipoproteins
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 10 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 5 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 25.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Inhibition of Urinary Angiotensinogen and the Reduction of Blood Pressure by SGLT2 Inhibition in Patients With Type 2 Diabetes
Sponsor: Tulane University School of Medicine
- To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study
Sponsor: Tulane University School of Medicine
Industry payments
Updated 16 Oct 2026
10 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Lilly USA, LLCProgram year202577 payments$85,129openpaymentsdata.cms.gov ↗
- Bayer Healthcare Pharmaceuticals Inc.Program year20252 payments
- SANOFI-AVENTIS U.S. LLCProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
70.6%GLP-1 receptor agonist41.6%Ozempic47%Mounjaro27%Trulicity20%Rybelsus6%Part D<11 patientsBiguanide (metformin)9.3%Metformin Hcl Er53%Metformin Hcl47%Part D<11 patients+ 4 more classes in this area
Hormonal (systemic)
18.9%l-Thyroxine18.9%Levothyroxine Sodium100%Part D≥32 patientsCardiovascular
10.5%Statin6.9%Atorvastatin Calcium54%Rosuvastatin Calcium46%Part D<11 patientsCholesterol absorption inhibitor3.6%Ezetimibe100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 16 Oct 2026
3 congress contributions (2018–2025) across ADA per OpenAlex. The most recent:
- 416-P: Relationship of Free Light Chains and Polymorphisms of the Endocannabinoid Receptor CNR1 and Fatty Acid Amide Hydrolase to Chronic Kidney Disease
ADA Scientific Sessions
ADA2025Presenting authorPoster - 423-P: Urinary Extracellular Vesicles in African Americans with Chronic Kidney Disease With and Without Type 2 Diabetes Mellitus
ADA Scientific Sessions
ADA2023Presenting authorPoster - The Effect of Liraglutide on 24-Hour Ambulatory Blood Pressure in Patients with T2DM—A Pilot Study
ADA Scientific Sessions
ADA2018Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Immunology and clinical approach to adult-onset type 1 diabetes
SMART-MD journal of precision medicine.
2025 - Effects of newer anti-hyperglycemic agents on cardiovascular outcomes in older adults: Systematic review and meta-analysis
Journal of Diabetes and its Complications
2024
Most-cited works
by citation count (OpenAlex)- 01
- 02Impact of a Natural Disaster on DiabetesArticle170 citations2009
- 03Weight Loss in Underserved Patients — A Cluster-Randomized TrialArticle147 citations2020
- 04
- 05
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/tina-thethi-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/tina-k-thethi-31035b10b
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Tina-Thethi
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
N.K.P. Salve Institute of Medical Sciences and Research Center (India)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →adventhealth.com ↗ - MPH
Tulane School of Public Health and Tropical Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →adventhealth.com ↗ - Board certified
American Board of Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →adventhealth.com ↗ - Board certified
Endocrinology, Diabetes and Metabolism
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →adventhealth.com ↗
Editorial & leadership roles
journal and society appointments- Fellow
American College of Endocrinology (FACE)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pri-med.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →adventhealth.com ↗
Secondary affiliations
appointments beyond the home institution- Faculty
Pri-Med
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pri-med.com ↗
Media & interviews
press, podcasts and appearances- ReachMD
Primary Care Today: Hot Topics in Diabetes, What Endocrinologists Are Talking About
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →reachmd.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Toni Choueiri, MD
Dana-Farber Cancer Institute
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Fred Saad, MD
Centre hospitalier de l'Université de Montréal (CHUM)